Kraig Biocraft Laboratories, Inc. KBLB
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.15M | -3.97M | -3.62M | -3.69M | -2.61M |
| Total Depreciation and Amortization | 100.90K | 58.30K | 57.80K | 105.40K | 90.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.22M | 1.13M | 852.80K | 852.10K | -82.50K |
| Change in Net Operating Assets | 792.80K | 896.90K | 923.80K | 877.90K | 886.60K |
| Cash from Operations | -2.04M | -1.88M | -1.79M | -1.85M | -1.72M |
| Capital Expenditure | -44.30K | -19.50K | -5.40K | -8.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 296.20K | 443.40K | 443.40K | 370.00K | 147.20K |
| Cash from Investing | 251.90K | 424.00K | 438.10K | 362.10K | 139.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -125.00K | -125.00K | -125.00K | -50.00K | -5.20K |
| Issuance of Common Stock | 4.52M | 4.08M | 2.60M | 1.93M | 856.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -10.00K | -10.00K | -10.00K |
| Cash from Financing | 4.39M | 3.95M | 2.47M | 1.87M | 841.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.61M | 2.49M | 1.12M | 375.60K | -736.10K |